in hypoxic ECs. 13 In atherosclerosis, HIF-1α activation correlates with disease progression and lesional inflammation. 16, 17 Vascular injury induces HIF-1α activation in smooth muscle cells and promotes neointima formation by upregulating CXCL12. 18 Here, we investigated the role of endothelial HIF-1α in atherosclerosis. We found that HIF-1α is activated in atherosclerotic ECs and deletion of endothelial HIF-1α reduces atherosclerosis, the lesional macrophage content, and the expression of CXCL1 and miR-19a in apolipoprotein E knockout (Apoe −/− ) mice. In ECs, moxLDL and LPA upregulated HIF-1α, which increased CXCL1-mediated monocyte adhesion by inducing miR-19a expression. These findings indicate that hyperlipidemia-induced HIF-1α in ECs promotes atherosclerosis by upregulating a proinflammatory miRNA.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

HIF-1α Expression in Atherosclerosis
HIF-1α expression was detectable in the nuclei of ECs covering human atherosclerotic lesions ( Figure S1A in the online-only Data Supplement). In Apoe −/− mice, nuclear HIF-1α expression was found in atherosclerotic ECs after 12 weeks of high fat diet (HFD) feeding but not in ECs from mice fed a normal diet ( Figure S1B ). These findings indicate that HIF-1α is activated in ECs during atherosclerosis. HFD feeding increased the Hif1a mRNA expression in the aortic arch, the thoracic and abdominal aorta, and the carotid artery of Apoe −/− mice ( Figure S2A ). In the aortic root, however, HFD feeding did not increase the expression of Hif1a ( Figure S2A ) and nuclear HIF-1α accumulation was found in the majority of vascular cells in Apoe −/− mice fed a normal diet ( Figure S2B ). Disturbed blood flow is essential for hyperlipidemiainduced endothelial inflammation and atherosclerosis. After a decline of the Hif1a mRNA expression at 1 day and 1 week after induction of blood flow disturbances in the carotid artery of Apoe −/− mice by partial ligation, the Hif1a transcript levels were increased after 2 and 4 week when compared with unligated carotid arteries ( Figure S2C ). Nuclear HIF-1α signals were detectable by immunostaining in ECs from partially ligated carotid arteries ( Figure 1A ).
HIF-1α Promotes Endothelial Inflammation
To investigate the role of HIF-1α on endothelial inflammation, EC-specific knockout of the Hif1a gene was induced ) mice using the Cre-lox system. Endothelial HIF-1α immunostaining ( Figure 1B ) and Hif1a mRNA expression ( Figure 1C ) were reduced in partially ligated carotid arteries from EC-Hif1a −/− mice when compared with EC-Hif1a +/+ mice. Moreover, the expression level of Cxcl1, Ccl2, and Tnfa but not those of Ccl5 and Mif were reduced in the carotid arteries of EC-Hif1a −/− mice compared with EC-Hif1a +/+ mice 2 weeks after partial ligation ( Figure  1C ). CXCL1 expressing ECs were reduced in partially ligated carotid arteries from EC-Hif1a −/− mice, as identified by dual immunofluorescence staining of CXCL1 and CD31 ( Figure  1D) . A similar effect of HIF-1α on CXCL1 expression was observed in atherosclerotic lesions in the aorta after feeding EC-Hif1a −/− mice and EC-Hif1a +/+ mice an HFD for 12 weeks ( Figure S3 ). These results indicate that activation of HIF-1α in atherosclerotic ECs enhances the expression of proinflammatory cytokines.
Endothelial HIF-1α Increases Atherosclerosis
To study the effect of endothelial HIF-1α on atherosclerosis, lesion formation was determined in EC-Hif1a −/− mice and EC-Hif1a +/+ mice. The lesion area was reduced in carotid arteries from EC-Hif1a −/− mice at 6 weeks after partial ligation and feeding an HFD (Figure 2A) . Moreover, the lesional accumulation of macrophages was lower in EC-Hif1a −/− mice than in EC-Hif1a +/+ mice ( Figure 2B ). The lesional smooth muscle cell and collagen type I content were similar in both groups ( Figure S4 ). To investigate whether HIF-1α in ECs contributes to vascular stenosis, the lumen of the partially ligated carotid arteries was quantified by computed tomographic angiography in vivo. The luminal volume was significantly reduced in the carotid arteries from EC-Hif1a −/− mice compared with EC-Hif1a +/+ mice ( Figure S5 ). Moreover, the lesion area and the lesional macrophage content were reduced in the aortas of EC-Hif1a −/− mice compared with EC-Hif1a +/+ mice after feeding an HFD for 12 weeks ( Figure S6 ). Deletion of the Hif1a gene in ECs did not affect serum cholesterol and triglyceride levels (Tables S2 and S3 ). Taken together, these results indicate that activation of HIF-1α in ECs enhances atherosclerotic lesion formation.
Endothelial HIF-1α Regulates CXCL1-Mediated Monocyte Adhesion
MoxLDL releases unsaturated LPA species, such as LPA20:4, which promote atherosclerosis by upregulating endothelial CXCL1 expression. 6 Accordingly, blocking LPA receptors using Ki16425 inhibited the moxLDL-induced release of CXCL1 from mouse aortic ECs (MAECs; Figure S7A ). In contrast to LPA18:0, treatment with LPA20:4 induced the expression of Cxcl1 and its secretion from MAECs through the activation of LPA receptors ( Figure S7B and S7C) . Moreover, moxLDL or LPA20:4 stimulation induced Hif1a at the mRNA and protein level in MAECs (Figure 3A and 3B; Figure S8 ). Treatment with Ki16425 diminished both moxLDL-and LPA20:4-induced Hif1a expression in MAECs ( Figure 3A and 3B). Silencing of Hif1a in MAECs using siRNA ( Figure  S9 ) decreased moxLDL-or LPA 20:4-induced Cxcl1 mRNA expression and CXCL1 protein secretion compared with nontargeting control siRNAs ( Figure 3C and 3D). Knockdown of Hif1a reduced the expression of Tnfa in moxLDL-stimulated MAECs, but not in LPA20:4-stimulated MAECs ( Figure 3C ). The role of endothelial HIF-1α in monocyte adhesion was studied using in vitro flow chamber assays. Treatment with mox-LDL or LPA20:4 increased monocyte adhesion compared with native LDL and LPA18:0 ( Figure S10 ). The moxLDL-and LPA20:4-induced monocyte adhesion was abolished by silencing Hif1a in MAECs ( Figure 3E and 3F). These results suggest that moxLDL-derived unsaturated LPAs promote CXCL1-dependent monocyte adhesion by upregulation HIF-1α.
HIF-1α Increases Endothelial Chemokine Expression by Upregulating MiR-19a
To study the effect of endothelial HIF-1α on the expression of miRNAs during atherosclerosis, miRNA expression profiling was performed in partially ligated carotid arteries from EC-Hif1a −/− and EC-Hif1a +/+ mice fed an HFD for 2 weeks using quantitative reverse transcription polymerase chain reaction arrays. Six miRNAs, including miR-19a and miR-9, were downregulated in EC-Hif1a −/− mice compared with EC-Hif1a +/+ mice ( Figure 4A ; Table S4 ). The downregulation of miR-19a in EC-Hif1a −/− mice occurred mainly in ECs as determined by combined in situ polymerase chain reaction B A
EC-Hif1a
-/- In vitro, stimulation with moxLDL increased the expression of miR-19a and HIF1a in human aortic ECs ( Figure  5A ; Figure S11 ). Silencing Hif1a using siRNAs reduced the expression of miR-19a in moxLDL-stimulated human aortic ECs ( Figure 5B ; Figure S12 ). Inhibition of miR-19a using antisense oligonucleotides diminished moxLDL-induced expression of CXCL1 and CCL2 mRNAs in human aortic ECs ( Figure 5C ). Conversely, transfection of human aortic ECs with miR-19a mimics substantially increased the expression of CXCL1 and CCL2 ( Figure 5D ), triggered nuclear translocation of the NF-κB protein p65 ( Figure S13 ), and enhanced monocyte adhesion to ECs ( Figure 5E ). Blocking the CXCL1 receptor CXCR2 on monocytes abrogated the effect of miR19a on monocyte adhesion ( Figure 5E ). These findings suggest that reduced expression of miR-19a diminishes endothelial Cxcl1 expression and NF-κB activation in EC-Hif1a −/− mice, and thereby limits atherogenic monocyte adhesion.
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Discussion
We found that enhanced HIF-1α activation in atherosclerotic ECs promotes the expression of CXCL1 and increases atherosclerosis. MoxLDL and its derivative LPA induced CXCL1 expression and monocyte adhesion by upregulating Hif1a expression in ECs. This effect of HIF-1α was because of increased expression of miR-19a, which triggers NF-κB activation, CXCL1 expression, and CXCL1-dependent monocyte adhesion. Taken together, our findings indicate that hyperlipidemia-induced HIF-1α activation in ECs contributes to atherogenic monocyte recruitment by upregulating miR-19a, which increases NF-κB activation and CXCL1 expression.
Hyperlipidemia increased HIF-1α expression and activation in atherosclerotic ECs. HIF-1α accumulates in hypoxic cells mainly because of increased protein stabilization. However, ECs produce ATP mainly by glycolysis, and oxygen supply via the blood stream to atherosclerotic ECs is not limited. 19 Therefore, nonhypoxic stimuli of HIF-1α activation, such as tumor necrosis factor-α and angiotensin II, which increase Hif1a transcription, may be more important for the activation of HIF-1α in ECs. 20 Unsaturated LPAs are produced during mild oxidation of LDL and induce the upregulation of Hif1a expression by activating LPA receptors in cancer cells and in smooth muscle cells. 21, 22 In line with these reports, our findings indicate that hyperlipidemia-induced endothelial HIF-1α activation is because of LPA receptor signaling triggered by moxLDL-derived LPAs. 6 In addition, LPAs activate proatherogenic NF-κB signaling in ECs. 6 Endothelial NF-κB activation may upregulate HIF-1α expression, which reciprocally amplifies NF-κB signaling and enhances angiotensin II-induced hypertensive kidney injury. 23 In quiescent ECs, the anti-inflammatory transcription factor Krüpple-like factor 2 limits NF-κB activation and HIF-1α accumulation. 24 However, disturbed flow downregulates endothelial Krüpple-like factor 2 expression and primes the endothelium for inflammatory activation by hyperlipidemia.
3 Accordingly, our findings indicate that disturbed flow is a prerequisite for hyperlipidemiainduced HIF-1α expression in ECs; however, the effect of disturbed flow alone on endothelial HIF-1α activation need to be studied in more detail.
The deletion of the Hif1a gene in ECs reduced the expression of proinflammatory cytokines, such as CXCL1 and tumor necrosis factor-α. HIF-1α transcriptional activity is also required for CXCL1 expression in myeloid cells, which mediates the survival of neutrophils in mycosis. 9 In ECs, preformed CXCL1 is stored in vesicles and released on activation by LPA. 6 CXCL1 is immobilized on the endothelial surface and induces proatherogenic monocyte adhesion by binding to its receptor CXCR2. 5, 6 LPA also increases CXCL1 mRNA expression in ECs by activating NF-κB. 6 Our results indicate that HIF-1α activation is essential for LPA-induced CXCL1 expression and monocyte adhesion, suggesting that HIF-1α amplifies NF-κB signaling in lipid-induced endothelial inflammation.
We found that Hif1a deletion selectively reduces the expression miR-19a in atherosclerotic ECs. In contrast to short-term exposure of ECs to high shear stress, which upregulates miR-19a expression, chronic high shear stress did not affect miR-19a expression levels. [25] [26] [27] Low shear stress upregulates the expression of miR-19a in oxLDL-stimulated ECs. 28-30 Accordingly, we found that miR-19a increases NF-κB activation in ECs, indicating that HIF-1α upregulates CXCL1 expression via miR-19a-induced NF-κB activation. In line with a proatherogenic role of miR-19a, the second miR-19 family member miR-19b, which differs only in 1 nucleotide from miR-19a, increases atherosclerosis. 31 In conclusion, we found that endothelial HIF-1α promotes the development of atherosclerosis by mediating the effects of unsaturated LPA on endothelial inflammation and monocyte recruitment through upregulation of miR-19a.
Perspectives
Our finding that endothelial HIF-1α activation in ECs by hyperlipidemia promotes atherosclerosis provides further insights in the transcriptional regulation of endothelial inflammation. HIF-1α promoted NF-κB activation by upregulating miR-19a, which in turn may enhance HIF-1α activation. Therefore, targeting this mutual activation of NF-κB and HIF-1α by inhibiting miR-19a in ECs may provide a novel approach in the treatment of atherosclerosis. ) were used throughout this study. Cre recombinase activity was induced by intraperitoneal injection of the mice with Tamoxifen (2 mg/20 g body weight; Sigma-Aldrich, Munich, Germany) dissolved in neutral oil (Migyol; Sasol, Hamburg, Germany) for 5 consecutive days. One week after the last injection, mice were either subjected to partial carotid ligation (PL) and fed a high fat diet (HFD, 0.15% cholesterol, Altromin, Lage, Germany) for 2, 4 or 6 weeks or fed the HFD for 12 weeks without partial ligation. All of the animal experiments were reviewed and approved by the local authorities in accordance with German animal protection law.
Partial ligation of carotid arteries
The left carotid arteries of 6-8-weeks old EC-Hif1a
-/-and EC-Hif1a +/+ mice were partially ligated and the mice were fed a HFD for the indicated time-points. Briefly, mice were anesthetized by injection with ketamine (80 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) and the external, the internal and the occipital artery were ligated allowing blood outflow only via the superior thyroid artery. Two or six weeks after the partial ligation, the carotid arteries were harvested after perfusion fixation with 4% paraformaldehyde (PFA, Sigma-Aldrich) and embedded in paraffin. The first 200 µm of the ligated carotid artery starting from bifurcation were analyzed.
Diet-induced atherosclerosis
Female EC-Hif1a
+/+ and EC-Hif1a -/-mice (age 6-8-weeks) were fed a HFD for 12 weeks. Mice were anesthetized by injection with ketamine (80 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.). The carotid arteries, aortic roots, and thoracoabdominal aorta were harvested after perfusion fixation with 4% PFA (Sigma-Aldrich). The tissues were embedded in paraffin.
Micro-computed tomography (CT) angiography
Micro-CT (TomoScope DUO, CT Imaging, Erlangen, Germany) scans was performed on partially ligated mice, as described previously 2 . A blood-pool contrast agent was intravenously injected and the luminal diameter of the common carotid artery was quantified within a distance of 1 mm from the bifurcation with the Imalytics Research workstation (Philips Technologie GmbH, Aachen, Germany). Three dimensional (3D) renderings of the carotid artery were created using the Definiens Developer XD software (Definiens, Munich, Germany).
Lesion quantification
Thoracoabdominal aortas were prepared en face and stained with Oil Red O stain. The Oil Red O-positive area was quantified from digital images of the aorta using image analysis software (ImageJ). The lesion area was analyzed in the carotid arteries by elastic van Gieson (EVG) staining of serial sections (4-5 µm thick) at an interval of 100 µm.
Immunostaining
Consecutive sections at an interval of 120 µm were immunostained for SM22 (rabbit polyclonal antibody, Abcam, Cambridge, UK), Mac-2 (clone M3/38 antibody, Cedarlane, Ontario, Canada) and collagen type-1 (rabbit polyclonal antibody, Cedarlane). The SM22, Mac-2 and collagen type-1 positive area in the lesion was quantified using ImageJ software.
Expression of HIF-1α was determined by immunostaining using a mouse monoclonal antibody against HIF-1α (Novus Biologicals, Cambridge, UK). Double immunostaining for Hif-1α or CXCL1 (rabbit polyclonal, Abcam) and CD31 (goat polyclonal, Santa Cruz, Heidelberg, Germany) or von Willebrand factor (vWF; rabbit polyclonal Ab, Abcam, Cambridge, UK) was performed in carotid artery sections or aortic root sections by sequential incubation of primary antibodies. Non-specific IgG served as a negative control. Primary antibodies were detected using fluorescently labelled secondary antibodies. The double immunostainings were analyzed by counting the number of CD31 and HIF-1α or CD31 and CXCL1 double positive cells in the lesions according to the presence of DAPI-(4'6-diamidino-2-phenylindole) stained nuclei and expressed as percentage of the total number of CD31 + cells.
Human atherosclerotic lesion specimens were obtained during carotid endarterectomy and fixed in PFA. The expression of endothelial specific HIF-1α was determined by double immunostaining for vWF (rabbit polyclonal, Abcam) and Hif-1α (mouse monoclonal, Novus Biologicals). The study protocol for the collection of human plaque samples was approved by the Ethics Committee of the Medical Faculty (RWTH Aachen University). Written informed consent was obtained from all participants.
Cell Culture
To obtain mouse aortic ECs (MAECs), the aortic arch and the thoracic aorta were cut into small pieces, which were aseptically placed on collagen gel. The ECs that migrated onto the gel after 5-6 days were isolated by digesting the gel with 0.3% collagenase and cultured in a tissue culture flask with endothelial cell growth medium (PAA, Pasching, Austria). The purity of the ECs was determined at passage 3 by lectin staining (Lycopersicon esculentum; Sigma). MAECs were seeded into collagen-coated 6-well plates (Millipore, Billerica, MA, USA) and grown to appropriate density in complete growth medium.
Human aortic ECs (HAEC; PromoCell, Heidelberg, Germany) were cultured in collagen-coated dishes (Millipore) using EC growth medium (PromoCell).
Following serum starvation for 18-20 h, the culture medium was replaced with fresh growth medium. LPA20:4 (Echelon, Salt Lake City, USA, 10 µmol/L), LPA18:0 (Avanti Polar Lipids, Alabaster, USA, 10 µmol/L), mildly-oxidized LDL (moxLDL; 50 µg/ml), native LDL (nLDL; 50 µg/ml) dissolved in PBS were added to the medium and incubated at 37 o C for 4-6 h. MAECs/HAECs were also treated with LPA20:4 (10 µmol/L) and the LPA receptor antagonist Ki16425 (Cayman Chemical, 100 µmol/L) or moxLDL (50 µg/ml) and Ki16425 (100 µmol/L) for 4-6 h. The medium was collected and stored at -80°C until measurement. The cells were harvested for RNA isolation.
Transfection of MAECs and HAECs
MAECs/HAECs were transfected with a small interfering RNA (siRNA) against Hif1a (Thermo Scientific, Braunschweig, Germany; Accell Mouse Hif1a (15251), Cat. # 040638-00-0002; Accell Human HIF1A (3091), Cat. # 004018-00-0005; 1µM) or a non-targeting siRNA for 72 h. MAECs were additionally incubated with or without LPA20:4 (10 µmol/L) or moxLDL (50 µg/ml) for 4 h. Cell culture medium was collected and stored at -80°C until measurement and the cells were harvested for RNA or protein isolation. Lipofectamine 2000 (Life Technologies, Darmstadt, Germany) was used to transfect HAECs with a locked nucleic acid (LNA)-miR-19a inhibitor (50 nM, miRCURY LNA TM microRNA Inhibitors; Exiqon, Vedbaek, Denmark), a miR-19a mimics (50 nM, mirVanaTM mimics; Life Technologies) or scrambled controls for 24h. Additional treatment with moxLDL (50 µg/ml) was performed for 6h, before the RNA was isolated.
For the p65 staining, HAECs were cultured in chamber slides (NuncTM Lab-TekTM; Thermo Scientific) and transfected with miR-19a-mimics or scrambled controls for 24h. HAECs were fixed with aceton/methanol (1:1) and p65 was determined using a polyclonal antibody against p65 (ab7970, Abcam).
Quantitative real time polymerase chain reaction (qRT-PCR)
Total RNA was isolated from carotid arteries and from cultured ECs using the RNA easy mini kit (Qiagen, Hilden, Germany) or NucleoSpin microRNA Kit (MachereyNagel GmbH & Co. KG, Düren, Germany). Reverse transcription was performed using M-MLV reverse transcriptase (Promega, Mannheim, Germany), TaqMan microRNA reverse transcription kit or high-capacity cDNA reverse transcription kit (both from Life Technologies). Hif1a mRNA and transcripts of proinflammatory cytokines were quantified by SYBR green PCR amplification in 7900HT fast real-time PCR system (Applied Biosystems, Darmstadt, Germany) (Table S1 ). Gapdh and Actb were used as reference genes. MiR-19a (Cat. # 000395) expression levels were quantified using TaqMan microRNA assays and TaqMan Universal PCR Master Mix (all from Life Technologies). RNU44 (Cat. # 001094) or sno135 (Cat. # 001230) were used as reference genes. The relative expression levels were normalized to a single or multiple reference genes scaled to the sample with the lowest expression and logarithmically transformed using Qbase PLUS software (Biogazelle NV, Zwijnaarde, Belgium).
MiRNA Real-time PCR Array
After reverse transcription and pre-amplification of total RNA using the Megaplex RT & Preamp Rodent Pool Set (Life Technologies), the samples were loaded onto preconfigured 384-well microfluidic TaqMan Array MicroRNA Cards for real-time polymerase chain reaction (RT-PCR) analyzing 641 mouse miRNAs, using the 7900HT Real-Time PCR System (all from Life Technologies). Data analysis was performed using Qbase PLUS software (Biogazelle NV) along with multiple internal control genes. The detection limit of the individual assays was defined as a CT < 40.
Flow Chamber Assay
Monocyte adhesion to MAECs stimulated with LPA20:4 (10 µmol/L), LPA18:0 (10 µmol/L), moxLDL (50 µg/ml) or nLDL (50 µg/ml) was measured using a parallel plate flow chamber, as described previously 3 . MonoMac6 cells (MM6; 0.5 × 10 6 cells/ml; Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) were suspended in HBSS-medium (1× Hanks Balanced Salt Solution, 1% FCS, 0.5% BSA) and labeled with calcein AM (1 μM; Life Technologies) for 30 min. For some experiments MM6 cells were treated with an antibody against C-X-C chemokine receptor type 2 (CXCR2; 20 μg/ml, clone 48311) or an isotype control IgG (20 μg/ml, clone 20102) (both from R&D Systems, Minneapolis, MN, USA). MM6 cells were perfused over MAECs in the lower chamber using a perfusion pump (WPI-SP100I, Berlin, Germany, shear rate of 1.5 dyn/cm 2 ). Monocyte-endothelial interactions were visualized by video-microscopy using a 10x magnification. For each experiment, recordings were made for 15 sec in one visual field and 5 random microscopic visual fields were analyzed for each experiment. After a 5 min observation period, monocytes that firmly attached to the MAECs were manually counted per visual field. Each experiment was repeated at least 3 times.
Lipid Analysis
The serum samples were analyzed for total cholesterol and triglycerides by dry chemistry using a Vitros 250 Analyzer (Ortho Clinical Diagnostics, Neckargemuend, Germany).
Preparation of mildly-oxidized LDL (moxLDL)
Human native LDL (1 mg/ml, Calbiochem, Darmstadt, Germany) was incubated with 5 μM CuSO4 at 37°C for 4 hours to prepare moxLDL. The LDL oxidation was stopped by adding 10 μM EDTA and the LDL was passed through PD-10 desalting column (GE Healthcare, Uppsala, Sweden). To prepare native LDL (nLDL) for experimental use as a negative control, all the above steps were performed except the addition of CuSO4. The protein concentration was measured using DC protein assay kit (Bio-Rad Laboratories GmbH, Munich, Germany) with BSA as a standard. The level of oxidation was evaluated by spectrophotometrically quantification the formation of thiobarbituric acid-reactive species (TBARS) at 532 nm (TBARS assay kit, Cayman Chemical, Michigan, USA). The moxLDL and nLDL were used within 14 days after preparation and stored at 4°C.
Enzyme-linked Immunosorbent Assay (ELISA)
The level of CXCL1 protein in the cell culture medium of MAECs was determined by a mouse CXCL1/KC ELISA kit (Ray Biotech, Inc, Norcross, USA) according to the manufacturer's protocol. The absorbance was measured at 450 nm with a microplate reader (SPECTRA Fluor Plus, Tecan).
Western Blot Analysis
The level of HIF-1α protein was determined in the cell lysate of MAECs or HAECs. ECs were lysed in RIPA buffer (Sigma-Aldrich) including protease inhibitors (CompleteProtease Inhibitor Cocktail, Roche, Basel, Switzerland). The cell lysate was resolved on SDS-PAGE gels and then transferred to nitrocellulose membranes. Proteins were detected using primary antibodies against HIF-1α (clone H-206, Santa Cruz Biotechnology, CA, USA), and GAPDH (clone 6C5, Millipore), and horse radish peroxidase conjugated (HRP)-conjugated secondary antibodies (Goat Anti-Mouse IgG HRP Affinity Purified PAb, R&D Systems; Goat Anti-Rabbit IgG HRP Affinity Purified PAb, Santa Cruz). Protein bands were visualized using an enhanced chemiluminescence detection system (ECL Advance, GE Healthcare Life Sciences) and a LAS 3000 Imager (Fuji Photo Film Co., Ltd., Tokyo, Japan) and were quantified using Multigauge software (Fuji Photo Film). Intensities of the HIF-1α bands were expressed as a percentage of those of the GAPDH bands.
In Situ Reverse Transcriptase PCR
Sections (5 µm thick) of carotid arteries were cooked in citrate buffer for 20 min using a microwave (600 W). One-step reverse transcriptase in situ PCR was performed using gene-specific Taq in situ primers (Sigma-Aldrich) (Table S1 ), SuperScript One-
Step RT-PCR with PlatinumTaq (Life Technologies), and digoxigenin-11-dUTPs (Roche). After washing with SSC buffer and blocking of biotin/avidin binding sites (Blocking Kit; Vector Laboratories, Peterborough, UK), the sections were incubated with HRP anti-digoxigenin sheep F'ab fragments (Roche) for 1 h at 37°C. The probes were visualized using a tyramide-based amplification system (TSA Plus Biotin; Perkin Elmer, Waltham, MA, USA) and DyLight 549-labeled streptavidin (Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA 4 .
Statistical Analysis
The miRNA real-time PCR array data were analyzed using Qbase PLUS software (Biogazelle NV) and are presented as mean values. All other data represent the mean ± SEM and were compared by either a 1-way or 2-way ANOVA followed by the Newman-Keuls or Bonferroni post-test, respectively, or an unpaired two-tailed Student t-test (Prism 6 software; Inc., La Jolla, CA, USA). P < 0.05 was considered to be statistically significant. 
